Fentanyl and fentanyl analogs are the drugs most often implicated in opioid overdose fatalities. Law and drug enforcement agencies are actively working to remove fentanyl-containing drugs from circulation; however, detection in the field can be challenging. Portable Raman spectroscopy is a valuable tool for identifying fentanyl, but the traditional method of identifying compounds requires comparison to a reference library on the system, which can limit the ability to detect novel fentanyl analogs. To overcome this challenge, a spectral barcoding technique was validated using fentanyl and a range of fentanyl analogs in addition to non-fentanyl confusants. Compared to traditional Raman techniques using an internal system library for identification, the spectral barcoding technique was better at identifying fentanyl-containing compounds while ruling out benign samples. Ultimately, this spectral barcoding technique allows for better identification in a constantly changing landscape of fentanyl analogs.
No takes yet. Share an insight, caveat, or question.
Wilcox et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: